SEO URLwww.firestrike.ai/deals/cidara-merck-acquisition-2026
acquisitionAnnounced · Feb 3, 2026PharmaceuticalsSource · CredibleArticle · Factual
Merck acquires Cidara
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
$9.2B
Target
Cidara
CDTX:NASDAQ
Acquirer
Merck
Full Acquisition
Status
Announced
Merck agreed to acquire Cidara. Reported deal value: $9.2B. Status: Announced. Sector: Pharmaceuticals. Target headquarters context: Location not specified.
This page summarizes publicly available information about the transaction as of 2026-02-03. Figures and status may change as filings and press coverage update.
Merck said its adjusted earnings forecast includes a one-time charge of about $9 billion related to the acquisition of the antiviral maker Cidara
Deal timeline
Announced
Feb 3, 2026 · ca.marketscreener.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Pharmaceuticals with a reported deal value of $9.2B. Figures and status may change as sources update.
Sources: ca.marketscreener.com · Primary article · FireStrike proprietary index